Oklahoma consumers and OG&E dispute a new law allowing utility rate increases during construction, raising concerns about ...
Truist raised the firm’s price target on Protagonist Therapeutics (PTGX) to $110 from $88 and keeps a Buy rating on the shares. 2026 is expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback